SML2018

GSK4027

≥98% (HPLC)

• Synonym(e): 4-Bromo-2-methyl-5-(((3R,5R)-1-methyl-5-phenylpiperidin-3-yl)-amino)pyridazin-3(2H)-one, 4-Bromo-2-methyl-5-[[(3R,5R)-1-methyl-5-phenyl-3-piperidinyl]amino]-3(2H)-pyridazinone
• Empirische Formel (Hill-System): C₁₇H₂₁BrN₄O
• CAS-Nummer: 2079896-25-4
• Molekulargewicht: 377.28
• UNSPSC-Code: 12352200
• NACRES: NA.77

Eigenschaften

• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 2 mg/mL, clear
• Lagertemp.: −20°C
• SMILES String: CN(C[C@H](C1)C2=CC=CC=C2)C[C@@H]1NC(C=NN(C3=O)C)=C3Br
• InChI: 1S/C17H21BrN4O/c1-21-10-13(12-6-4-3-5-7-12)8-14(11-21)20-15-9-19-22(2)17(23)16(15)18/h3-7,9,13-14,20H,8,10-11H2,1-2H3/t13-,14+/m0/s1
• InChIKey: VZAFGXCWAWRULT-UONOGXRCSA-N

Beschreibung

Biochem./physiol. Wirkung

GSK4027 is a cell penetrant, potent and selective inhibitor of PCAF/GCN5 bromodomain [p300/CBP-associated factor (PCAF)/general control nonderepressible 5 (GCN5) bromodomain].

It acts as a chemical probe for PCAF/GCN5.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable